Latest Updates
|
January 2010 Marketed Drug
Updates and Additions
|
Brand Name
|
Generic Name
|
Other Designation
|
Ceplene (formerly Maxamine and EpiLeukin) |
Histamine dihydrochloride |
|
Herceptin |
Trastuzumab |
RG597, formerly rhuMAb HER2 |
Avastin |
Bevacizumab |
rhuMAb-VEGF, NSC-704865, R435, RG435 |
Arzerra |
Ofatumumab |
HuMax-CD20, GSK1841157 |
Gardasil, Silgard (Eastern Europe) |
Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine |
|
Tasigna |
Nilotinib |
AMN107, AMN-107 |
Afinitor (cancer), Certican (immunosuppression) |
Everolimus |
RAD001, RAD001C |
Zometa |
Zoledronate, zoledronic acid |
ZOL 446/ CGP 42446 |
Gleevec (USA, Canada, Israel), Glivec (Europe) |
Imatinib mesylate |
STI-571, STI571, formerly CGP-57148B |
Xeloda |
Capecitabine |
Ro 09-1978, RG340 |
Amnolake, Amnoid, Amnoleuk, Tamibaro |
Tamibarotene |
Am80, Am-80, TOS-80T |
|
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887
INFO@NEWMEDINC.COM
|